AtaiBeckley (ATAI) Receivables - Other (2020 - 2026)

AtaiBeckley (ATAI) posted Receivables - Other of $326000.0 for Q3 2021, down 63.78% sequentially from $900000.0 in Q4 2020.

Analysis

AtaiBeckley (ATAI) Receivables - Other (2020 - 2026) Analysis & Trends

AtaiBeckley's Receivables - Other history runs 1 years deep, the most recent figure standing at $600000.0 for Q1 2026.

Quarterly Receivables - Other changed N/A year-over-year to $326000.0 in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $326000.0 (changed N/A YoY) and the FY2020 annual result came in at $900000.0, changed N/A from the prior year.
Receivables - Other for Q1 2026 stood at $600000.0.
Over five years, Receivables - Other peaked at $900000.0 in Q4 2020 and troughed at $326000.0 in Q3 2021.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	138.47 Bn	130.62 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.18 Bn	77.19 Bn	3.93 Bn
3	Argenx Se	63.38 Bn	58.19 Bn	1.37 Bn
4	Moderna	58.09 Bn	52.95 Bn	52.00 Mn
5	Revolution Medicines	44.33 Bn	44.33 Bn	-
6	BeOne Medicines	40.02 Bn	34.92 Bn	1.53 Bn
7	Alnylam Pharmaceuticals	35.57 Bn	32.27 Bn	992.69 Mn
8	Royalty Pharma	28.45 Bn	27.61 Bn	-
9	Insmed	27.48 Bn	26.32 Bn	358.27 Mn
10	AtaiBeckley	1.61 Bn	1.61 Bn	-

Historic Data

Download Data